Identification of Lynch syndrome among people newly diagnosed with endometrial cancer: a prospective audit (Contributed by Prof. Emma J Davidson) - https://t.co/nYVwEIOHLq
Physical activity interventions in women treated for endometrial cancer: a scoping review https://t.co/aUVBidC9cV #LocalAuthorThursday @ProfEmmaCrosbie
Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer https://t.co/0wtoKYck5F #LocalAuthorThursday@BurghelG@fionalalloo @ProfEmmaCrosbie
Two new Cochrane reviews show that HPV vaccines are effective in preventing cervical cancer.
@ProfEmmaCrosbie, Cancer Prevention and Early Detection Co-Theme Lead at Manchester BRC, was involved in the reviews.
📽️ Watch this video to find out more 👇
https://t.co/U2DlPcEhKN
🗞️ In the @Independent: HPV vaccine does prevent cervical cancer
Scientists including @ProfEmmaCrosbie, Cancer Prevention and Early Detection Co-Theme Lead at Manchester BRC, have provided the most comprehensive evidence on HPV vaccination.
Read more 👇
https://t.co/r7ydrYUekM
This Black History Month, we celebrate Black leaders at the MCRC, highlighting their proudest moments, lessons learned, and hopes for the future.
https://t.co/MWetb3YEnh
A new blood test could improve ovarian cancer detection.
Prof Emma Crosbie, Cancer Prevention and Early Detection Co-Theme Lead, is 1 of the authors on 2 related papers published in the British Journal of Cancer.
📰 Media coverage here:
https://t.co/TeIjifeCNU
Manchester scientists have found a new blood test could accurately detect ovarian cancer early.
@ProfEmmaCrosbie, Cancer Prevention and Early Detection Co-Theme Lead at Manchester BRC said: “AOA Dx’s platform has the potential to significantly improve patient care and outcomes."
We are inviting people with Lynch syndrome to take part in a survey exploring awareness and views of preimplantation genetic testing.#Lynchsyndrome@LynchSyndromeUK@ECTeamSMH.
To take part, PLEASE CLICK LINK BELOW
https://t.co/zj9rT3TgRG
@AmericanCancer we are laser focussed on amplifying the patient voice. I was thrilled to be able to lead the panel at #PrevConf25 on people at high-risk for cancer made up of those at high-risk and advocates. We need to be much better in communicating with pts and families!
Leading causes of death after a diagnosis of endometrial cancer: a systematic review and meta-analysis https://t.co/qy29rNNBLL #LocalAuthorThursday#EndometrialCancer @ProfEmmaCrosbie
How team science tackled gender inequalities in Lynch syndrome-associated cancer care https://t.co/mkPGwjVJ4s #LocalAuthorThursday#LynchSyndrome @ProfEmmaCrosbie
Thought provoking keynote lecture from Prof Adam Balen on the evolution of assisted conception since the first IVF birth & the ethical dilemmas the new technology brings including the potential for artificial wombs, solo genetic parenting & gene editing.' How far should we go?'
Applications invited for a bright, motivated O&G trainee to take up a @tommys Research Fellowship unlocking the microarchitecture of the cervix in #PTB - loads of clinical skills in TVS and cerclage to be acquired along the way too! https://t.co/Q9supy83Ou